Downward, Julian
The Francis Crick Institute
23 papers on CoChatORCID 0000-0002-2331-4729
Most cited papers
- Verified
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine
Cancer Genomics and DiagnosticsChromatin Remodeling and Cancer
Cited by 7,774
- Verified
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences
Downward, J., Yarden, Y., Mayes, E., Scrace, G., Totty, N., Stockwell, P., Ullrich, A., Schlessinger, J., & Waterfield, M. D. (1984) · Nature
HER2/EGFR in Cancer ResearchCancer-related Molecular Pathways
Cited by 2,516
- Verified
Phosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature
Protein Kinase Regulation and GTPase SignalingPI3K/AKT/mTOR signaling in cancer
Cited by 1,954
- Verified
Akt Phosphorylates the Yes-Associated Protein, YAP, to Induce Interaction with 14-3-3 and Attenuation of p73-Mediated Apoptosis
Basu, S., Totty, N. F., Irwin, M. S., Sudol, M., & Downward, J. (2003) · Molecular Cell
Hippo pathway signaling and YAP/TAZPI3K/AKT/mTOR signaling in cancer
Cited by 843
- Verified
Lung adenocarcinoma promotion by air pollutants
Hill, W., Lim, E. L., Weeden, C. E., Lee, C., Augustine, M., Chen, K., Kuan, F.-C., Marongiu, F., Evans, E. J., Moore, D. A., et al. (2023) · Nature
Air Quality and Health ImpactsCarcinogens and Genotoxicity Assessment
Cited by 808
- Verified
RAS Interaction with PI3K: More Than Just Another Effector Pathway
Castellano, E., & Downward, J. (2011) · Genes & Cancer
Protein Kinase Regulation and GTPase SignalingPI3K/AKT/mTOR signaling in cancer
Cited by 762
- Verified
Autophosphorylation sites on the epidermal growth factor receptor
Downward, J., Parker, P., & Waterfield, M. D. (1984) · Nature
HER2/EGFR in Cancer ResearchProtein Kinase Regulation and GTPase Signaling
Cited by 704
- Verified
PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death
Gandhi, S., Wood-Kaczmar, A., Yao, Z., Plun-Favreau, H., Deas, E., Klupsch, K., Downward, J., Latchman, D. S., Tabrizi, S. J., Wood, N. W., et al. (2009) · Molecular Cell
Parkinson's Disease Mechanisms and TreatmentsMitochondrial Function and Pathology
Cited by 682
- Verified
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
Coelho, M. A., de Carné Trécesson, S., Rana, S., Zecchin, D., Moore, C., Molina-Arcas, M., East, P., Spencer-Dene, B., Nye, E., Barnouin, K., et al. (2017) · Immunity
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 653
- Verified
The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma
Miess, H., Dankworth, B., Gouw, A. M., Rosenfeldt, M., Schmitz, W., Jiang, M., Saunders, B., Howell, M., Downward, J., Felsher, D. W., et al. (2018) · Oncogene
Ferroptosis and cancer prognosisCancer, Hypoxia, and Metabolism
Cited by 361
- Verified
PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons
Wood-Kaczmar, A., Gandhi, S., Yao, Z., Abramov, A. S. Y., Miljan, E. A., Keen, G., Stanyer, L., Hargreaves, I., Klupsch, K., Deas, E., et al. (2008) · PLoS ONE
Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling
Cited by 316
- Verified
R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways
Marte, B. M., Rodriguez-Viciana, P., Wennström, S., Warne, P. H., & Downward, J. (1997) · Current Biology
Protein Kinase Regulation and GTPase SignalingPI3K/AKT/mTOR signaling in cancer
Cited by 223
- Verified
Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer
Molina-Arcas, M., Moore, C., Rana, S., van Maldegem, F., Mugarza, E., Romero-Clavijo, P., Herbert, E., Horswell, S., Li, L.-S., Janes, M. R., et al. (2019) · Science Translational Medicine
Lung Cancer Treatments and MutationsProtein Kinase Regulation and GTPase Signaling
Cited by 203
- Verified
Coordinate Direct Input of Both KRAS and IGF1 Receptor to Activation of PI3 kinase in KRAS -Mutant Lung Cancer
Molina-Arcas, M., Hancock, D. C., Sheridan, C., Kumar, M. S., & Downward, J. (2013) · Cancer Discovery
Protein Kinase Regulation and GTPase SignalingPI3K/AKT/mTOR signaling in cancer
Cited by 157
- Verified
Exploiting the therapeutic implications of KRAS inhibition on tumor immunity
Molina-Arcas, M., & Downward, J. (2024) · Cancer Cell
Cancer Immunotherapy and BiomarkersProtein Kinase Regulation and GTPase Signaling
Cited by 152
- Verified
Involvement of MINK, a Ste20 Family Kinase, in Ras Oncogene-Induced Growth Arrest in Human Ovarian Surface Epithelial Cells
Nicke, B., Bastien, J., Khanna, S. J., Warne, P. H., Cowling, V., Cook, S. J., Peters, G., Delpuech, O., Schulze, A., Berns, K., et al. (2005) · Molecular Cell
Protein Kinase Regulation and GTPase SignalingProtein Tyrosine Phosphatases
Cited by 108
- Verified
Targeting RAS and PI3K in lung cancer
Downward, J. (2008) · Nature Medicine
PI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase Signaling
Cited by 80
- Verified
A palmitoyl transferase chemical–genetic system to map ZDHHC-specific S-acylation
Ocasio, C. A., Baggelaar, M. P., Sipthorp, J., Losada de la Lastra, A., Tavares, M., Volarić, J., Soudy, C., Storck, E. M., Houghton, J. W., Palma-Duran, S. A., et al. (2024) · Nature Biotechnology
Click Chemistry and ApplicationsLipid metabolism and biosynthesis
Cited by 56
- Verified
SnapShot: Class I PI3K Isoform Signaling
Fritsch, R., & Downward, J. (2013) · Cell
PI3K/AKT/mTOR signaling in cancerMetabolism, Diabetes, and Cancer
Cited by 42
- Verified
Mutant KRAS at the heart of tumor immune evasion
van Maldegem, F., & Downward, J. (2020) · Immunity
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 32
- Verified
High throughput application of the NanoBiT Biochemical Assay for the discovery of selective inhibitors of the interaction of PI3K-p110α with KRAS
Ismail, M., Davies, G., Sproat, G., Monteverde, T., Tart, J., Acebrón-García-de-Eulate, M., Gohlke, A., Hancock, D., Adhikari, S., Stefanovic-Barrett, S., et al. (2024) · SLAS Discovery
PI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase Signaling
Cited by 6
- Verified
Abstract 4029: Combination of KRASG12C(ON) and SHP2 inhibitors overcomes adaptive resistance and enhances anti-tumor immunity
Anastasiou, P., Mugarza, E., Boumelha, J., Rana, S., Moore, C., Molina-Arcas, M., & Downward, J. (2022) · Cancer Research
Lung Cancer Treatments and MutationsProtein Kinase Regulation and GTPase Signaling
Cited by 3
- Verified
Targeting a KRAS neoantigen peptide vaccine to DNGR-1+ dendritic cells
Ambler, R., Von Karstedt, S., & Downward, J. (2020) · European Journal of Cancer
Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers
Cited by 1
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free